These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16426980)

  • 1. NICE to see the bigger picture.
    Lancet Neurol; 2006 Feb; 5(2):103. PubMed ID: 16426980
    [No Abstract]   [Full Text] [Related]  

  • 2. The post-modern world of Alzheimer's disease trials: how much is an ADAS-cog point worth in central London?
    Schneider LS
    Int J Geriatr Psychiatry; 2006 Jan; 21(1):9-13. PubMed ID: 16353164
    [No Abstract]   [Full Text] [Related]  

  • 3. Aligning the evidence with practice: NICE guidelines for drug treatment of Alzheimer's disease.
    Ballard C; Corbett A; Sharp S
    Expert Rev Neurother; 2011 Mar; 11(3):327-9. PubMed ID: 21375436
    [No Abstract]   [Full Text] [Related]  

  • 4. NICE vindicated in UK's High Court.
    Horton R
    Lancet; 2007 Aug; 370(9587):547-8. PubMed ID: 17707735
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of mild Alzheimer's disease post-NICE.
    Connelly PJ; Passmore AP; Lawlor BA
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1262-3. PubMed ID: 17503543
    [No Abstract]   [Full Text] [Related]  

  • 6. NICE recommends drugs for moderate Alzheimer's disease.
    Mayor S
    BMJ; 2006 Jan; 332(7535):195. PubMed ID: 16439382
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescribing policy with dementia drugs: the UK NICE experience.
    Dening T
    Maturitas; 2009 Oct; 64(2):59-60. PubMed ID: 19767159
    [No Abstract]   [Full Text] [Related]  

  • 8. Patients with mild Alzheimer's disease should have access to drugs, says draft NICE guidance.
    Kmietowicz Z
    BMJ; 2010 Oct; 341():c5562. PubMed ID: 20926475
    [No Abstract]   [Full Text] [Related]  

  • 9. Ten years of cholinesterase inhibitors.
    Rodda J; Walker Z
    Int J Geriatr Psychiatry; 2009 May; 24(5):437-42. PubMed ID: 19367617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NICE proposes to withdraw Alzheimer's drugs from NHS.
    Kmietowicz Z
    BMJ; 2005 Mar; 330(7490):495. PubMed ID: 15746112
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-dementia drugs.
    Allen H
    Int J Geriatr Psychiatry; 1999 Apr; 14(4):239-43. PubMed ID: 10340181
    [No Abstract]   [Full Text] [Related]  

  • 12. NICE guidelines unfair for Alzheimer's disease.
    Lowery K
    Br J Nurs; 2001 Nov 8-21; 10(20):1314. PubMed ID: 11873223
    [No Abstract]   [Full Text] [Related]  

  • 13. NICE, devolution and drugs for dementia.
    Findlay DJ
    Br J Hosp Med (Lond); 2007 Feb; 68(2):66-7; discussion 67-9. PubMed ID: 17370701
    [No Abstract]   [Full Text] [Related]  

  • 14. Raw deal for dementia patients in the UK.
    Lancet Neurol; 2007 Oct; 6(10):839. PubMed ID: 17884665
    [No Abstract]   [Full Text] [Related]  

  • 15. [Questions and theses of pharmacological therapeutic options of Alzheimer's dementia with acetylcholinesterase inhibitors].
    van den Bussche H
    Z Gerontol Geriatr; 2005 Sep; 38 Suppl 1():I18-20. PubMed ID: 16189731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease.
    Bosanquet N; Yeates A
    Pharmacoeconomics; 2006; 24(6):623-5; author reply 625-6. PubMed ID: 16761908
    [No Abstract]   [Full Text] [Related]  

  • 17. Drugs for Alzheimer's disease. Guidelines for prescribing cholinesterase inhibitors in Australia are similar to those in UK.
    Noble JM
    BMJ; 2001 Nov; 323(7321):1128. PubMed ID: 11725756
    [No Abstract]   [Full Text] [Related]  

  • 18. [A reply to Pfizer: Still no reason to change SBU's conclusions on drugs against dementia].
    Edhag O; Norlund A
    Lakartidningen; 2007 Jan 10-16; 104(1-2):55. PubMed ID: 17323745
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholinesterase inhibitors for Alzheimer's disease: variations in clinical practice in the north-west of England.
    Purandare N; Swarbrick C; Fischer A; Burns A
    Int J Geriatr Psychiatry; 2006 Oct; 21(10):961-4. PubMed ID: 16927408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cholinesterase inhibitors in Alzheimer disease: preliminary recommendations for the practice].
    Schölzel-Dorenbos CJ; Jellesma-Eggenkamp MJ
    Ned Tijdschr Geneeskd; 1999 Jan; 143(2):122-3. PubMed ID: 10086120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.